Hemoglobin disorders such as HbS and HbC affect millions of people worldwide. Countries around the world spend substantial resources each year identifying carriers, often relying on detailed ...
To be presented at the 2026 ASGCT conference in Boston, MA TAMPA, FL, UNITED STATES, April 30, 2026 /EINPresswire.com/ ...
Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts SessionCompany to ...
Adenosine base editing restarted fetal hemoglobin expression in cells from patients with sickle cell disease. Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease ...
In neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson’s, and Alzheimer’s, healthy brain cells are damaged by aberrant reactive oxygen species (ROS). A potential ...
AstraZeneca Plc (NASDAQ:AZN) released data from the Phase 3 ALPHA trial of danicopan as an add-on to the standard of care for paroxysmal nocturnal hemoglobinuria (PNH). The data showed that danicopan ...
What Is an MCHC Blood Test? A mean corpuscular hemoglobin concentration (MCHC) blood test measures the amount of a protein called hemoglobin in your red blood cells. It’s one of many measurements ...
Hereditary spherocytosis is a genetic disorder in which the red blood cells (RBCs) are fragile and burst easily. These disc-shaped cells, which have a lifespan of 120 days, contain hemoglobin and ...
Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results